CN103495028B - Chinese medicine preparation for treating prosopalgia - Google Patents

Chinese medicine preparation for treating prosopalgia Download PDF

Info

Publication number
CN103495028B
CN103495028B CN201310468698.5A CN201310468698A CN103495028B CN 103495028 B CN103495028 B CN 103495028B CN 201310468698 A CN201310468698 A CN 201310468698A CN 103495028 B CN103495028 B CN 103495028B
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
herba
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310468698.5A
Other languages
Chinese (zh)
Other versions
CN103495028A (en
Inventor
田雅霞
刘洪菊
顾连霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310468698.5A priority Critical patent/CN103495028B/en
Publication of CN103495028A publication Critical patent/CN103495028A/en
Application granted granted Critical
Publication of CN103495028B publication Critical patent/CN103495028B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a Chinese medicine preparation for treating prosopalgia. The traditional Chinese medicine believes that the pathogenesis of the prosopalgia disease is divided into two classes of external infection and internal injury, but most of pains caused by any reason relate to fire pathogen. Thus, the traditional Chinese medicines, such as woolyfruit stylophorum herb, akebiaquinata, Chinese sweetleaf root, saruma root, mosla chinensis maxim, saussurea nigrescens, veined inula root, whorledleaf solomonseal rhizome, multijugous pricklyash root, pungent litse branchlet, viola muehldorfii, trifid sopubia herb and ferrosic oxide, with the effects of expelling wind and cold pathogens, tonifying qi, invigorating circulation of blood, clearing heat, relieving exterior syndrome, calming liver wind, and activating meridians to stop pain, are selected to be decocted into decoction by water. The total effective rate can be up to 97.7% and much better than 79.5% of a control group by a clinical test.

Description

One treats prosopalgic Chinese medicine composition
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to one and treat prosopalgic Chinese medicine preparation.
Background technology
Trigeminal neuralgia is one of Neurology Department commonly encountered diseases, is the severe pain of nervi trigeminus areal area repeated relapsing, transience.Pain each sustainable several seconds, outbreak every day is tens of time to hundreds of times, pain as electric shock sample, the sample that lancinates, burn sample or acupuncture sample.Trigeminal neuralgia is the most common person in all neuralgias, and primary disease is mainly in grows up and old people, and the patient Ke Da 70% ~ 80% of more than 40 years old, women is slightly more than male.Western medicine trigeminal neuralgia generally has good analgesic effect, but often because it has comparatively serious side effect, and patient can not be tolerated, cause adhering to treatment, and fall short of success for lack of final effort.
Summary of the invention
The object of this invention is to provide one and treat prosopalgic Chinese medicine preparation.The traditional Chinese medical science thinks that the cause of disease of primary disease can be divided into the large class of diseases caused by exogenous pathogenic factor, internal injury two, but the pain no matter which kind of reason causes is all many relevant with pathogenic fire.Sayed as in " card is controlled accurate strong ", " prosopodynia all belongs to fire and contains ".Diseases caused by exogenous pathogenic factor caused often by ailment said due to cold or exposure hold under the arm cold, hold fire under the arm, to hold expectorant under the arm assorted and cause a disease; Interior the wounded is many caused by Yangming dryness-heat, feelings will internal injury.Treat primary disease with expelling wind and cold, inrigorating qi and promoting blood circulation, clearing away heat and expelling pathogen in the exterior, suppressing the hyperactive liver to relieve the wind syndrome, removing obstruction in the collateral to relieve pain for principle.
The object of the invention is to be achieved through the following technical solutions, the prosopalgic Chinese medicine preparation of this treatment is made up of the Chinese medicine of following weight portion: Herba Stylophori Lasiocapi 5-10 part, Caulis Akebiae 5-10 part, Radix Symplocoris chinensis 10-20 part, Radix Sarumatis henryi 2-5 part, Herba Moslae Chinensis 10-20 part, Herba saussureae nigrescentis 10-15 part, Radix Inulae Nervosae 30-50 part, Rhizoma Polygonati Verticillati 10-15 part, Radix Zanthoxyli multijugi 20-30 part, Caulis Litseae pungentis 5-15 part, Radix violae delavayi 5-10 part, Herba sopubiae Trifidae 10-15 part, pulvis ferri (ferrosic oxide) 15-25 part.
Preferably, Herba Stylophori Lasiocapi 8 parts, Caulis Akebiae 8 parts, Radix Symplocoris chinensis 15 parts, Radix Sarumatis henryi 3 parts, Herba Moslae Chinensis 15 parts, Herba saussureae nigrescentis 125 parts, Radix Inulae Nervosae 40 parts, Rhizoma Polygonati Verticillati 12 parts, Radix Zanthoxyli multijugi 25 parts, Caulis Litseae pungentis 10 parts, Radix violae delavayi 8 parts, Herba sopubiae Trifidae 12 parts, pulvis ferri (ferrosic oxide) 20 parts.
Above-mentioned Chinese medicine decocting is made decoction by preparation method.
Fang Zhong: Herba Stylophori Lasiocapi's circulation of qi promoting dissipating blood stasis, hemostasis and pain-relieving; Caulis Akebiae clearing away heat and promoting diuresis, blood circulation and channel invigorating; Radix Symplocoris chinensis clearing away heat-damp and promoting diuresis, reduce phlegm preventing the attack (or recurrence) of malaria; Radix Sarumatis henryi regulating QI to relieve pain; Herba Moslae Chinensis is regulated the flow of vital energy, invigorate blood circulation, pain relieving; Herba saussureae nigrescentis expelling wind and removing dampness, heat clearing away of invigorating blood circulation; Grass becomes clever cold-dispelling, the meridian dredging; Rhizoma Polygonati Verticillati suppressing the hyperactive liver to relieve the wind syndrome, yin nourishing easing the affected liver; Radix Zanthoxyli multijugi jiao dispelling cold and analgesia; Caulis Litseae pungentis expelling wind and cold, warming middle-JIAO is regulated the flow of vital energy; Radix violae delavayi, Herba sopubiae Trifidae promoting the flow of QI in the collateral by warming the meridian, removing damp and stopping pain; Pulvis ferri (ferrosic oxide) checking hyperfunction of the liver for relieving convulsion.
Clinical data
This group of physical data patient 88 example, is out-patient, by table of random number, case is divided at random treatment group and each 44 examples of matched group.Treatment group man 20 example, female 24 example; 23 ~ 54 years old age, average 37.1 years old, the course of disease 1 ~ 3 year.Matched group man 19 example, female 25 example; Age is 26 ~ 54 years old, average 37.5 years old, the course of disease 1 ~ 3 year.Two groups of patients compare in age, sex, the course of disease, and no significant difference (P>0.05), has comparability.
Diagnostic criteria (1) is in ictal severe pain, and the persistent period is short, general several seconds to 2 ~ 3mi n.(2) pain is confined to, in nervi trigeminus areal area, not surmount trifacial distribution.(3) facial area has trigger point.(4) the no positive finding of intermission neurologic check.
Therapeutic Method treatment group takes Chinese medicine preparation of the present invention, take Herba Stylophori Lasiocapi 8g, Caulis Akebiae 8g, Radix Symplocoris chinensis 15g, Radix Sarumatis henryi 3g, Herba Moslae Chinensis 15g, Herba saussureae nigrescentis 125g, Radix Inulae Nervosae 40g, Rhizoma Polygonati Verticillati 12g, Radix Zanthoxyli multijugi 25g, Caulis Litseae pungentis 10g, Radix violae delavayi 8g, Herba sopubiae Trifidae 12g, pulvis ferri (ferrosic oxide) 20g, decocting becomes decoction, potion, divided and sooner or later took for 2 times every day; Matched group takes carbamazepine 100 ~ 200mg/ day, then increases 100mg every day, and increase to gradually and maintain 400 ~ 800mg/ day, maximum is no more than 1600mg/ day.A course for the treatment of on the seven, two groups all serve on two courses for the treatment of.
Criterion of therapeutical effect is cured: panic attacks disappears; Effective: pain relief when attack times reduces or shows effect; Invalid: symptom has no and takes a turn for the better or increase the weight of.
Therapeutic outcome two groups treats comparitive study after two courses for the treatment of, and treatment group 44 example, wherein cures 22 examples (50%), effective 21 examples (47.7%), invalid 1 example (2.3%), total effective rate 97.7%; Matched group 44 example, wherein cures 15 examples (34%), effective 20 examples (45.5%), no effect 9 (20.5%), total effective rate 79.5%.Two groups are compared, and treatment group cure rate, total effective rate are obviously better than matched group, have comparability (P<0.05).
There is no obvious adverse reaction after treatment group drug administration, after matched group drug administration, have 15 routine patients' existence untoward reaction in various degree, as blurred vision or diplopia, diarrhoea, unrelenting headache, drowsiness, unable etc.
Detailed description of the invention
Embodiment one: take Herba Stylophori Lasiocapi 8g, Caulis Akebiae 8g, Radix Symplocoris chinensis 15g, Radix Sarumatis henryi 3g, Herba Moslae Chinensis 15g, Herba saussureae nigrescentis 125g, Radix Inulae Nervosae 40g, Rhizoma Polygonati Verticillati 12g, Radix Zanthoxyli multijugi 25g, Caulis Litseae pungentis 10g, Radix violae delavayi 8g, Herba sopubiae Trifidae 12g, pulvis ferri (ferrosic oxide) 20g, makes decoction by above-mentioned Chinese medicine decocting.
Embodiment two: take Herba Stylophori Lasiocapi 5g, Caulis Akebiae 10g, Radix Symplocoris chinensis 10g, Radix Sarumatis henryi 5g, Herba Moslae Chinensis 10g, Herba saussureae nigrescentis 15g, Radix Inulae Nervosae 30g, Rhizoma Polygonati Verticillati 15g, Radix Zanthoxyli multijugi 20g, Caulis Litseae pungentis 15g, Radix violae delavayi 5g, Herba sopubiae Trifidae 10g, pulvis ferri (ferrosic oxide) 25g, makes decoction by above-mentioned Chinese medicine decocting.
Embodiment three: take Herba Stylophori Lasiocapi 10g, Caulis Akebiae 5g, Radix Symplocoris chinensis 20g, Radix Sarumatis henryi 2g, Herba Moslae Chinensis 20g, Herba saussureae nigrescentis 10g, Radix Inulae Nervosae 50g, Rhizoma Polygonati Verticillati 10g, Radix Zanthoxyli multijugi 30g, Caulis Litseae pungentis 5g, Radix violae delavayi 10g, Herba sopubiae Trifidae 15g, pulvis ferri (ferrosic oxide) 15g, makes decoction by above-mentioned Chinese medicine decocting.

Claims (2)

1. treat a prosopalgic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Stylophori Lasiocapi 5-10 part, Caulis Akebiae 5-10 part, Radix Symplocoris chinensis 10-20 part, Radix Sarumatis henryi 2-5 part, Herba Moslae Chinensis 10-20 part, Herba saussureae nigrescentis 10-15 part, Radix Inulae Nervosae 30-50 part, Rhizoma Polygonati Verticillati 10-15 part, Radix Zanthoxyli multijugi 20-30 part, Caulis Litseae pungentis 5-15 part, Radix violae delavayi 5-10 part, Herba sopubiae Trifidae 10-15 part, pulvis ferri (ferrosic oxide) 15-25 part.
2. one according to claim 1 treats prosopalgic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Stylophori Lasiocapi 8 parts, Caulis Akebiae 8 parts, Radix Symplocoris chinensis 15 parts, Radix Sarumatis henryi 3 parts, Herba Moslae Chinensis 15 parts, Herba saussureae nigrescentis 125 parts, Radix Inulae Nervosae 40 parts, Rhizoma Polygonati Verticillati 12 parts, Radix Zanthoxyli multijugi 25 parts, Caulis Litseae pungentis 10 parts, Radix violae delavayi 8 parts, Herba sopubiae Trifidae 12 parts, pulvis ferri (ferrosic oxide) 20 parts.
CN201310468698.5A 2013-09-25 2013-09-25 Chinese medicine preparation for treating prosopalgia Expired - Fee Related CN103495028B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310468698.5A CN103495028B (en) 2013-09-25 2013-09-25 Chinese medicine preparation for treating prosopalgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310468698.5A CN103495028B (en) 2013-09-25 2013-09-25 Chinese medicine preparation for treating prosopalgia

Publications (2)

Publication Number Publication Date
CN103495028A CN103495028A (en) 2014-01-08
CN103495028B true CN103495028B (en) 2015-05-20

Family

ID=49860350

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310468698.5A Expired - Fee Related CN103495028B (en) 2013-09-25 2013-09-25 Chinese medicine preparation for treating prosopalgia

Country Status (1)

Country Link
CN (1) CN103495028B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225166A (en) * 2011-06-02 2011-10-26 长治市郊区黄碾镇中心卫生院 Medicament for treating prosopalgia and preparation method thereof
CN102847125A (en) * 2012-09-26 2013-01-02 张永红 Drug for treating prosopalgia and preparation method of drug

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225166A (en) * 2011-06-02 2011-10-26 长治市郊区黄碾镇中心卫生院 Medicament for treating prosopalgia and preparation method thereof
CN102847125A (en) * 2012-09-26 2013-01-02 张永红 Drug for treating prosopalgia and preparation method of drug

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中药治疗原发性三叉神经痛的体会;高启德;《中华老年口腔医学杂志》;20070430;第5卷(第4期);205-206 *

Also Published As

Publication number Publication date
CN103495028A (en) 2014-01-08

Similar Documents

Publication Publication Date Title
CN103356854A (en) Traditional Chinese medicine for treating rheumatism
CN104096141A (en) Traditional Chinese medical composition for treating allergic conjunctivitis
CN102824622B (en) Preparation method of traditional Chinese medicine lotion for treating closed fracture with syndrome of palpitation
CN104825561A (en) Traditional Chinese medicine for treating arthritis
CN104257899A (en) Traditional Chinese medicine for treating trigeminal neuralgia
CN103961671A (en) Chili-wild pepper-pepper rheumatism pain relieving solution
CN103495028B (en) Chinese medicine preparation for treating prosopalgia
CN104288597B (en) A kind of Chinese medicine composition for treating herpes zoster
CN102614479B (en) Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma
CN102397492A (en) Medicinal liquor
CN105617042A (en) Traditional Chinese medicine composition for treating headache
CN105833034A (en) Traditional Chinese medicine composition
CN105497779A (en) Traditional Chinese medicine patch for treating acute lumbar sprain
CN104606523A (en) Traditional Chinese medicine composition treating children&#39;s measles
CN105012612A (en) Traditional Chinese medicine composition for treating hyperosteogeny
CN104258326A (en) Traditional Chinese medicine used for treating scapulohumeral periarthritis
CN101983645A (en) Medicament for treating acute appendicitis
CN102949653B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN105434821A (en) Traditional Chinese medicine preparation for treating prosopalgia
CN104958718A (en) Medicine for treating infertility
CN103142709A (en) Medicament for treating cold
CN105031150A (en) Traditional Chinese medicine decoction for treating prosopalgia
CN104740565A (en) Traditional Chinese medicine composition for treating cold injury
CN104173931A (en) Traditional Chinese medicine composition for treating trauma
CN104547915A (en) Traditional Chinese medicine composition for treating traumatic injury and medicinal liquor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150520

Termination date: 20150925

EXPY Termination of patent right or utility model